The Benefits of Smoking Cessation on Patients with COPD – A Narrative Review

[1] “Chronic obstructive pulmonary disease (COPD).” Accessed: Mar. 02, 2025. [Online]. Available: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd) Search in Google Scholar

[2] E. T. 3 min read, “Smoking & COPD,” COPD.net. Accessed: Mar. 02, 2025. [Online]. Available: https://copd.net/basics/causes-risk-factors/smoking Search in Google Scholar

[3] Q. Song, P. Chen, and X.-M. Liu, “The role of cigarette smoke-induced pulmonary vascular endothelial cell apoptosis in COPD,” Respir. Res., vol. 22, no. 1, p. 39, Feb. 2021, doi: 10.1186/s12931-021-01630-1. Search in Google Scholar

[4] J. A. Riesco, B. Alcázar, J. A. Trigueros, A. Campuzano, J. Perez, and J. L. Lorenzo, “Active smoking and COPD phenotype: distribution and impact on prognostic factors,” Int. J. Chron. Obstruct. Pulmon. Dis., vol. 12, pp. 1989–1999, 2017, doi: 10.2147/COPD.S135344. Search in Google Scholar

[5] A. Fazleen and T. Wilkinson, “Early COPD: current evidence for diagnosis and management,” Ther. Adv. Respir. Dis., vol. 14, p. 1753466620942128, 2020, doi: 10.1177/1753466620942128. Search in Google Scholar

[6] “WHO report on the global tobacco epidemic, 2023: protect people from tobacco smoke.” Accessed: Jan. 20, 2025. [Online]. Available: https://www.who.int/publications/i/item/9789240077164 Search in Google Scholar

[7] M. I. Saeed et al., “TOB-STOP-COP (TOBacco STOP in COPd trial): study protocol-a randomized open-label, superiority, multicenter, two-arm intervention study of the effect of ‘high-intensity’ vs. ‘low-intensity’ smoking cessation intervention in active smokers with chronic obstructive pulmonary disease,” Trials, vol. 21, no. 1, p. 730, Aug. 2020, doi: 10.1186/s13063-020-04653-z. Search in Google Scholar

[8] D. Campagna et al., “Smoking and diabetes: dangerous liaisons and confusing relationships,” Diabetol. Metab. Syndr., vol. 11, p. 85, 2019, doi: 10.1186/s13098-019-0482-2. Search in Google Scholar

[9] K. Larsson, “Aspects on pathophysiological mechanisms in COPD,” J. Intern. Med., vol. 262, no. 3, pp. 311–340, Sep. 2007, doi: 10.1111/j.1365-2796.2007.01837.x. Search in Google Scholar

[10] J. C. S. Holtjer et al., “Identifying risk factors for COPD and adult-onset asthma: an umbrella review,” Eur. Respir. Rev. Off. J. Eur. Respir. Soc., vol. 32, no. 168, p. 230009, Jun. 2023, doi: 10.1183/16000617.0009-2023. Search in Google Scholar

[11] M. Shnaigat, S. Downie, and H. Hosseinzadeh, “Effectiveness of Health Literacy Interventions on COPD Self-Management Outcomes in Outpatient Settings: A Systematic Review,” COPD, vol. 18, no. 3, pp. 367–373, Jun. 2021, doi: 10.1080/15412555.2021.1872061. Search in Google Scholar

[12] N. A. Rigotti, “Smoking cessation in patients with respiratory disease: existing treatments and future directions,” Lancet Respir. Med., vol. 1, no. 3, pp. 241–250, May 2013, doi: 10.1016/S2213-2600(13)70063-8. Search in Google Scholar

[13] V. Austin, P. J. Crack, S. Bozinovski, A. A. Miller, and R. Vlahos, “COPD and stroke: are systemic inflammation and oxidative stress the missing links?,” Clin. Sci. Lond. Engl. 1979, vol. 130, no. 13, pp. 1039–1050, Jul. 2016, doi: 10.1042/CS20160043. Search in Google Scholar

[14] S. Dey, M. S. Eapen, C. Chia, A. V. Gaikwad, P. A. B. Wark, and S. S. Sohal, “Pathogenesis, clinical features of asthma COPD overlap, and therapeutic modalities,” Am. J. Physiol. Lung Cell. Mol. Physiol., vol. 322, no. 1, pp. L64–L83, Jan. 2022, doi: 10.1152/ajplung.00121.2021. Search in Google Scholar

[15] N. L. Benowitz, J. Samet, N. Soleimanpour, and B. W. Chaffee, “Biomarkers of improved health outcomes after smoking cessation,” Addict. Neurosci., vol. 5, p. 100054, Mar. 2023, doi: 10.1016/j.addicn.2022.100054. Search in Google Scholar

[16] K. H. Czarnecka-Chrebelska, D. Mukherjee, S. V. Maryanchik, and M. Rudzinska-Radecka, “Biological and Genetic Mechanisms of COPD, Its Diagnosis, Treatment, and Relationship with Lung Cancer,” Biomedicines, vol. 11, no. 2, p. 448, Feb. 2023, doi: 10.3390/biomedicines 11020448. Search in Google Scholar

[17] Y.Wang, J. Xu, Y. Meng, I. M. Adcock, and X. Yao, “Role of inflammatory cells in airway remodeling in COPD,” Int. J. Chron. Obstruct. Pulmon. Dis., vol. 13, pp. 3341–3348, 2018, doi: 10.2147/COPD.S176122. Search in Google Scholar

[18] A. J. A. McGuinness and E. Sapey, “Oxidative Stress in COPD: Sources, Markers, and Potential Mechanisms,” J. Clin. Med., vol. 6, no. 2, p. 21, Feb. 2017, doi: 10.3390/jcm6020021. Search in Google Scholar

[19] M. Hikichi, K. Mizumura, S. Maruoka, and Y. Gon, “Pathogenesis of chronic obstructive pulmonary disease (COPD) induced by cigarette smoke,” J. Thorac. Dis., vol. 11, no. Suppl 17, pp. S2129–S2140, Oct. 2019, doi: 10.21037/jtd.2019.10.43. Search in Google Scholar

[20] P. J. Barnes, S. D. Shapiro, and R. A. Pauwels, “Chronic obstructive pulmonary disease: molecular and cellular mechanisms,” Eur. Respir. J., vol. 22, no. 4, pp. 672–688, Oct. 2003, doi: 10.1183/09031936.03.00040703. Search in Google Scholar

[21] H. G. Dailah, “Therapeutic Potential of Small Molecules Targeting Oxidative Stress in the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Comprehensive Review,” Mol. Basel Switz., vol. 27, no. 17, p. 5542, Aug. 2022, doi: 10.3390/molecules27175542. Search in Google Scholar

[22] X. Zhao, Q. Zhang, and R. Zheng, “The interplay between oxidative stress and autophagy in chronic obstructive pulmonary disease,” Front. Physiol., vol. 13, p. 1004275, 2022, doi: 10.3389/fphys.2022.1004275. Search in Google Scholar

[23] B. M. Fischer, E. Pavlisko, and J. A. Voynow, “Pathogenic triad in COPD: oxidative stress, protease-antiprotease imbalance, and inflammation,” Int. J. Chron. Obstruct. Pulmon. Dis., vol. 6, pp. 413–421, 2011, doi: 10.2147/COPD.S10770. Search in Google Scholar

[24] S. Safiri et al., “Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019,” BMJ, vol. 378, p. e069679, Jul. 2022, doi: 10.1136/bmj-2021-069679. Search in Google Scholar

[25] S. Kotlyarov, “The Role of Smoking in the Mechanisms of Development of Chronic Obstructive Pulmonary Disease and Atherosclerosis,” Int. J. Mol. Sci., vol. 24, no. 10, p. 8725, May 2023, doi: 10.3390/ijms24108725. Search in Google Scholar

[26] D. H. Au et al., “The effects of smoking cessation on the risk of chronic obstructive pulmonary disease exacerbations,” J. Gen. Intern. Med., vol. 24, no. 4, pp. 457–463, Apr. 2009, doi: 10.1007/s11606-009-0907-y. Search in Google Scholar

[27] J. R. Hurst et al., “Susceptibility to exacerbation in chronic obstructive pulmonary disease,” N. Engl. J. Med., vol. 363, no. 12, pp. 1128–1138, Sep. 2010, doi: 10.1056/NEJMoa0909883. Search in Google Scholar

[28] A. Domenech et al., “High risk of subclinical atherosclerosis in COPD exacerbator phenotype,” Respir. Med., vol. 141, pp. 165–171, Aug. 2018, doi: 10.1016/j.rmed.2018.07.004. Search in Google Scholar

[29] A. Forder et al., “Mechanisms Contributing to the Comorbidity of COPD and Lung Cancer,” Int. J. Mol. Sci., vol. 24, no. 3, p. 2859, Feb. 2023, doi: 10.3390/ijms24032859. Search in Google Scholar

[30] M. Underner, J. Perriot, and G. Peiffer, “[Smoking cessation in smokers with chronic obstructive pulmonary disease],” Rev. Mal. Respir., vol. 31, no. 10, pp. 937–960, Dec. 2014, doi: 10.1016/j.rmr.2014.07.001. Search in Google Scholar

[31] P. Tønnesen, K. Mikkelsen, and L. Bremann, “Nurseconducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support,” Chest, vol. 130, no. 2, pp. 334–342, Aug. 2006, doi: 10.1378/chest.130.2.334. Search in Google Scholar

[32] B.W. M. Willemse, D. S. Postma, W. Timens, and N. H. T. ten Hacken, “The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation,” Eur. Respir. J., vol. 23, no. 3, pp. 464–476, Mar. 2004, doi: 10.1183/09031936.04.00012704. Search in Google Scholar

[33] Y. Liu et al., “Smoking duration, respiratory symptoms, and COPD in adults aged ≥45 years with a smoking history,” Int. J. Chron. Obstruct. Pulmon. Dis., vol. 10, pp. 1409–1416, 2015, doi: 10.2147/COPD.S82259. Search in Google Scholar

[34] Centers for Disease Control and Prevention (US), National Center for Chronic Disease Prevention and Health Promotion (US), and Office on Smoking and Health (US), How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. in Publications and Reports of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US), 2010. Accessed: Jan. 20, 2025. [Online]. Available: http://www.ncbi.nlm.nih.gov/books/NBK53017/ Search in Google Scholar

[35] A. Pezzuto, C. Spoto, B. Vincenzi, and G. Tonini, “Short-term effectiveness of smoking-cessation treatment on respiratory function and CEA level,” J. Comp. Eff. Res., vol. 2, no. 3, pp. 335–343, May 2013, doi: 10.2217/cer.13.25. Search in Google Scholar

[36] E. Maci, F. Comito, A. M. Frezza, G. Tonini, and A. Pezzuto, “Lung nodule and functional changes in smokers after smoking cessation short-term treatment,” Cancer Invest., vol. 32, no. 8, pp. 388–393, Oct. 2014, doi: 10.3109/07357907.2014.919308. Search in Google Scholar

[37] M. Iwaoka and T. Tsuji, “Twelve Weeks of Successful Smoking Cessation Therapy with Varenicline Reduces Spirometric Lung Age,” Intern. Med. Tokyo Jpn., vol. 55, no. 17, pp. 2387–2392, 2016, doi: 10.2169/internalmedicine.55.6844. Search in Google Scholar

[38] P. D. Scanlon et al., “Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study,” Am. J. Respir. Crit. Care Med., vol. 161, no. 2 Pt 1, pp. 381–390, Feb. 2000, doi: 10.1164/ajrccm.161.2.9901044. Search in Google Scholar

[39] J. Dhariwal et al., “Smoking cessation in COPD causes a transient improvement in spirometry and decreases micronodules on high-resolution CT imaging,” Chest, vol. 145, no. 5, pp. 1006–1015, May 2014, doi: 10.1378/chest.13-2220. Search in Google Scholar

[40] P. N. Lee and J. S. Fry, “Systematic review of the evidence relating FEV1 decline to giving up smoking,” BMC Med., vol. 8, p. 84, Dec. 2010, doi: 10.1186/1741-7015-8-84. Search in Google Scholar

[41] D. P. Tashkin, S. Rennard, J. Taylor Hays, D. Lawrence, J. P. Marton, and T. C. Lee, “Lung function and respiratory symptoms in a 1-year randomized smoking cessation trial of varenicline in COPD patients,” Respir.Med., vol. 105, no. 11, pp. 1682–1690, Nov. 2011, doi: 10.1016/j.rmed.2011.04.016. Search in Google Scholar

[42] J. Vestbo et al., “Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team,” Am. J. Respir. Crit. Care Med., vol. 189, no. 9, pp. 1022–1030, May 2014, doi: 10.1164/rccm.201311-2006PP. Search in Google Scholar

[43] P. Tønnesen, “Smoking cessation and COPD,” Eur. Respir. Rev. Off. J. Eur. Respir. Soc., vol. 22, no. 127, pp. 37–43, Mar. 2013, doi: 10.1183/09059180.00007212. Search in Google Scholar

[44] O. Hatayama, T. Kobayashi, K. Fujimoto, and K. Kubo, “Utility of single-slice high-resolution CT in upper lung field combined with low-dose spiral CT for lung-cancer screening in the detection of emphysema,” Intern. Med. Tokyo Jpn., vol. 46, no. 18, pp. 1519–1525, 2007, doi: 10.2169/internalmedicine.46.6343. Search in Google Scholar

[45] H. Omori, K. Fujimoto, and T. Katoh, “Computed-tomography findings of emphysema: correlation with spirometric values,” Curr. Opin. Pulm. Med., vol. 14, no. 2, pp. 110–114, Mar. 2008, doi: 10.1097/MCP.0b013e3282f 3f18f. Search in Google Scholar

[46] K. Kurashima et al., “High resolution CT and bronchial reversibility test for diagnosing COPD,” Respirol. Carlton Vic, vol. 10, no. 3, pp. 316–322, Jun. 2005, doi: 10.1111/j.1440-1843.2005.00701.x. Search in Google Scholar

[47] F. A. A. Mohamed Hoesein et al., “CT-quantified emphysema in male heavy smokers: association with lung function decline,” Thorax, vol. 66, no. 9, pp. 782–787, Sep. 2011, doi: 10.1136/thx.2010.145995. Search in Google Scholar

[48] J.-P. Charbonnier et al., “Airway wall thickening on CT: Relation to smoking status and severity of COPD,” Respir. Med., vol. 146, pp. 36–41, Jan. 2019, doi: 10.1016/j.med.2018.11.014. Search in Google Scholar

[49] G. R. Washko et al., “Lung volumes and emphysema in smokers with interstitial lung abnormalities,” N. Engl. J. Med., vol. 364, no. 10, pp. 897–906, Mar. 2011, doi: 10.1056/NEJMoa1007285. Search in Google Scholar

[50] M. Remy-Jardin, J.-L. Edme, C. Boulenguez, J. Remy, I. Mastora, and A. Sobaszek, “Longitudinal follow-up study of smoker’s lung with thin-section CT in correlation with pulmonary function tests,” Radiology, vol. 222, no. 1, pp. 261–270, Jan. 2002, doi: 10.1148/radiol.2221001154. Search in Google Scholar

[51] J. E. McDonough et al., “Small-airway obstruction and emphysema in chronic obstructive pulmonary disease,” N. Engl. J. Med., vol. 365, no. 17, pp. 1567–1575, Oct. 2011, doi: 10.1056/NEJMoa1106955. Search in Google Scholar

[52] S. A. Chang, “Smoking and type 2 diabetes mellitus,” Diabetes Metab. J., vol. 36, no. 6, pp. 399–403, Dec. 2012, doi: 10.4093/dmj.2012.36.6.399. Search in Google Scholar

[53] J. A. Riesco, M. Hidalgo, D. Chipayo, J. J. Gómez, and F. Zaragozá, “Profile of Cardiovascular Disease Patients Who are Diagnosed with COPD in a Smoking-Cessation Unit,” Adv. Ther., vol. 37, no. 8, pp. 3562–3570, Aug. 2020, doi: 10.1007/s12325-020-01403-0. Search in Google Scholar

[54] S. M. Mohiuddin, A. N. Mooss, C. B. Hunter, T. L. Grollmes, D. A. Cloutier, and D. E. Hilleman, “Intensive smoking cessation intervention reduces mortality in highrisk smokers with cardiovascular disease,” Chest, vol. 131, no. 2, pp. 446–452, Feb. 2007, doi: 10.1378/chest.06-1587. Search in Google Scholar

[55] P.W. F. Wilson, “Smoking, smoking cessation, and risk of cardiovascular disease,” Curr. Treat. Options Cardiovasc. Med., vol. 8, no. 4, pp. 276–281, Aug. 2006, doi: 10.1007/s11936-006-0048-0. Search in Google Scholar

[56] N. S. Godtfredsen and E. Prescott, “Benefits of smoking cessation with focus on cardiovascular and respiratory comorbidities,” Clin. Respir. J., vol. 5, no. 4, pp. 187–194, Oct. 2011, doi: 10.1111/j.1752-699X.2011.00262.x. Search in Google Scholar

[57] A. A. Ahmed et al., “Risk of Heart Failure and Death After Prolonged Smoking Cessation: Role of Amount and Duration of Prior Smoking,” Circ. Heart Fail., vol. 8, no. 4, pp. 694–701, Jul. 2015, doi: 10.1161/CIRCHEARTFAILURE.114.001885. Search in Google Scholar

[58] A. Bakhru and T. P. Erlinger, “Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination Survey,” PLoS Med., vol. 2, no. 6, p. e160, Jun. 2005, doi: 10.1371/journal.pmed.0020160. Search in Google Scholar

[59] C. Bullen, “Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease,” Expert Rev. Cardiovasc. Ther., vol. 6, no. 6, pp. 883–895, Jul. 2008, doi: 10.1586/14779072.6.6.883. Search in Google Scholar

[60] A. L. Pipe, M. J. Eisenberg, A. Gupta, R. D. Reid, N. G. Suskin, and J. A. Stone, “Smoking cessation and the cardiovascular specialist: Canadian Cardiovascular Society position paper,” Can. J. Cardiol., vol. 27, no. 2, pp. 132–137, 2011, doi: 10.1016/j.cjca.2010.12.060. Search in Google Scholar

[61] G. Gallucci, A. Tartarone, R. Lerose, A. V. Lalinga, and A. M. Capobianco, “Cardiovascular risk of smoking and benefits of smoking cessation,” J. Thorac. Dis., vol. 12, no. 7, pp. 3866–3876, Jul. 2020, doi: 10.21037/jtd.2020.02.47. Search in Google Scholar

[62] D. Girard et al., “Long-term smoking cessation and heart rate dynamics in an aging healthy cohort: Is it possible to fully recover?,” Environ. Res., vol. 143, no. Pt A, pp. 39–48, Nov. 2015, doi: 10.1016/j.envres.2015.09.023. Search in Google Scholar

[63] A. J. Dobson, H. M. Alexander, R. F. Heller, and D. M. Lloyd, “How soon after quitting smoking does risk of heart attack decline?,” J. Clin. Epidemiol., vol. 44, no. 11, pp. 1247–1253, 1991, doi: 10.1016/0895-4356(91)90157-5. Search in Google Scholar

[64] K. K. Teo et al., “Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a casecontrol study,” Lancet Lond. Engl., vol. 368, no. 9536, pp. 647–658, 2006, doi: 10.1016/S0140-6736(06)69249-0. Search in Google Scholar

[65] D. Twardella, D. Rothenbacher, H. Hahmann, B. Wusten, and H. Brenner, “The underestimated impact of smoking and smoking cessation on the risk of secondary cardiovascular disease events in patients with stable coronary heart disease: prospective cohort study,” J. Am. Coll. Cardiol., vol. 47, no. 4, pp. 887–889, Feb. 2006, doi: 10.1016/j.jacc.2005.11.028. Search in Google Scholar

[66] A. P. Silva et al., “Influence of smoking cessation drugs on blood pressure and heart rate in patients with cardiovascular disease or high risk score: real life setting,” BMC Cardiovasc. Disord., vol. 16, p. 2, Jan. 2016, doi: 10.1186/s12872-015-0180-4. Search in Google Scholar

[67] B. P. Yawn and A. Kaplan, “Co-morbidities in people with COPD: a result of multiple diseases, or multiple manifestations of smoking and reactive inflammation?,” Prim. Care Respir. J. J. Gen. Pract. Airw. Group, vol. 17, no. 4, pp. 199–205, Dec. 2008, doi: 10.3132/pcrj.2008.00021. Search in Google Scholar

[68] E. Barreiro, V. Bustamante, V. Curull, J. Gea, J. L. López-Campos, and X. Muñoz, “Relationships between chronic obstructive pulmonary disease and lung cancer: biological insights,” J. Thorac. Dis., vol. 8, no. 10, pp. E1122–E1135, Oct. 2016, doi: 10.21037/jtd.2016.09.54. Search in Google Scholar

[69] D. Amicizia et al., “Systematic Review of Lung Cancer Screening: Advancements and Strategies for Implementation,” Healthc. Basel Switz., vol. 11, no. 14, p. 2085, Jul. 2023, doi: 10.3390/healthcare11142085. Search in Google Scholar

[70] R. Uliński, I. Kwiecień, and J. Domagała-Kulawik, “Lung Cancer in the Course of COPD-Emerging Problems Today,” Cancers, vol. 14, no. 15, p. 3819, Aug. 2022, doi: 10.3390/cancers14153819. Search in Google Scholar

[71] A. Cavaillès et al., “Comorbidities of COPD,” Eur. Respir. Rev. Off. J. Eur. Respir. Soc., vol. 22, no. 130, pp. 454–475, Dec. 2013, doi: 10.1183/09059180.00008612. Search in Google Scholar

[72] R. P. Young and R. J. Hopkins, “How the genetics of lung cancermay overlap with COPD,” Respirol. Carlton Vic, vol. 16, no. 7, pp. 1047–1055, Oct. 2011, doi: 10.1111/j.1440-1843.2011.02019.x. Search in Google Scholar

[73] G. J. Criner et al., “Chronic Obstructive Pulmonary Disease and Lung Cancer: A Review for Clinicians,” Chronic Obstr. Pulm. Dis. Miami Fla, vol. 9, no. 3, pp. 454–476, Jul. 2022, doi: 10.15326/jcopdf.2022.0296. Search in Google Scholar

[74] K. Szalontai et al., “Chronic Obstructive Pulmonary Disease: Epidemiology, Biomarkers, and Paving theWay to Lung Cancer,” J. Clin. Med., vol. 10, no. 13, p. 2889, Jun. 2021, doi: 10.3390/jcm10132889. Search in Google Scholar

[75] T. Goldkorn, S. Filosto, and S. Chung, “Lung injury and lung cancer caused by cigarette smoke-induced oxidative stress: Molecular mechanisms and therapeutic opportunities involving the ceramide-generating machinery and epidermal growth factor receptor,” Antioxid. Redox Signal., vol. 21, no. 15, pp. 2149–2174, Nov. 2014, doi: 10.1089/ars.2013.5469. Search in Google Scholar

[76] V. A. Kiri, J. Soriano, G. Visick, and L. Fabbri, “Recent trends in lung cancer and its association with COPD: an analysis using the UK GP Research Database,” Prim. Care Respir. J. J. Gen. Pract. Airw. Group, vol. 19, no. 1, pp. 57–61, Mar. 2010, doi: 10.4104/pcrj.2009.00048. Search in Google Scholar

[77] D. J. Magliano, E. J. Boyko, and IDF Diabetes Atlas 10th edition scientific committee, IDF DIABETES ATLAS, 10th ed. in IDF Diabetes Atlas. Brussels: International Diabetes Federation, 2021. Accessed: Jan. 20, 2025. [Online]. Available: http://www.ncbi.nlm.nih.gov/booksNBK581934/ Search in Google Scholar

[78] V. Durlach et al., “Smoking and diabetes interplay: A comprehensive review and joint statement,” Diabetes Metab., vol. 48, no. 6, p. 101370, Nov. 2022, doi: 10.1016/j.diabet.2022.101370. Search in Google Scholar

[79] G. J. Molla et al., “Smoking and Diabetes Control in Adults With Type 1 and Type 2 Diabetes: A Nationwide Study From the 2018 National Program for Prevention and Control of Diabetes of Iran,” Can. J. Diabetes, vol. 44, no. 3, pp. 246–252, Apr. 2020, doi: 10.1016/j.jcjd.2019.07.002. Search in Google Scholar

[80] I. Berlin, V. Durlach, D. Thomas, B. Verges, A.-L. Le Faou, and Working Group on Smoking and Diabetes, “Tobacco smoking and diabetes. A comparative survey among diabetologists and smoking cessation specialists,” Prim. Care Diabetes, vol. 18, no. 2, pp. 241–245, Apr. 2024, doi: 10.1016/j.pcd.2024.01.009. Search in Google Scholar

[81] C. P. Wen, T. Y. D. Cheng, S. P. Tsai, H. L. Hsu, H. T. Chan, and C. C. Hsu, “Exploring the relationships between diabetes and smoking: with the development of glucose equivalent concept for diabetes management,” Diabetes Res. Clin. Pract., vol. 73, no. 1, pp. 70–76, Jul. 2006, doi: 10.1016/j.diabres.2005.12.005. Search in Google Scholar

[82] T. E. Dorner, H. Brath, and A. Kautzky-Willer, “Sexspecific trends in smoking prevalence over seven years in different Austrian populations: results of a time-series cross-sectional analysis,” BMJ Open, vol. 10, no. 9, p. e035235, Sep. 2020, doi: 10.1136/bmjopen-2019-035235. Search in Google Scholar

[83] P. M. Nilsson, S. Gudbjornsdottir, B. Eliasson, J. Cederholm, and Steering Committee of the Swedish National Diabetes Register, “Smoking is associated with increased HbA1c values and microalbuminuria in patients with diabetes--data from the National Diabetes Register in Sweden,” Diabetes Metab., vol. 30, no. 3, pp. 261–268, Jun. 2004, doi: 10.1016/s1262-3636(07)70117-9. Search in Google Scholar

[84] S. G. Wannamethee, A. G. Shaper, I. J. Perry, and British Regional Heart Study, “Smoking as amodifiable risk factor for type 2 diabetes in middle-aged men,” Diabetes Care, vol. 24, no. 9, pp. 1590–1595, Sep. 2001, doi: 10.2337/diacare.24.9.1590. Search in Google Scholar

[85] F. Moayeri, Y.-S. A. Hsueh, D. Dunt, and P. Clarke, “Smoking Cessation and Quality of Life: Insights From Analysis of Longitudinal Australian Data, an Application for Economic Evaluations,” Value Health J. Int. Soc. Pharmacoeconomics Outcomes Res., vol. 24, no. 5, pp. 724–732, May 2021, doi: 10.1016/j.jval.2020.11.022. Search in Google Scholar

[86] G. Taylor, A. McNeill, A. Girling, A. Farley, N. Lindson-Hawley, and P. Aveyard, “Change in mental health after smoking cessation: systematic review and meta-analysis,” BMJ, vol. 348, p. g1151, Feb. 2014, doi: 10.1136/bmj.g1151. Search in Google Scholar

[87] G. M. Taylor et al., “Smoking cessation for improving mental health,” Cochrane Database Syst. Rev., vol. 3, no. 3, p. CD013522, Mar. 2021, doi: 10.1002/14651858. CD013522.pub2. Search in Google Scholar

[88] M. E. Piper, S. Kenford, M. C. Fiore, and T. B. Baker, “Smoking cessation and quality of life: changes in life satisfaction over 3 years following a quit attempt,” Ann. Behav. Med. Publ. Soc. Behav. Med., vol. 43, no. 2, pp. 262–270, Apr. 2012, doi: 10.1007/s12160-011-9329-2. Search in Google Scholar

[89] J. Tian, A. J. Venn, L. Blizzard, G. C. Patton, T. Dwyer, and S. L. Gall, “Smoking status and health-related quality of life: a longitudinal study in young adults,” Qual. Life Res. Int. J. Qual. Life Asp. Treat. Care Rehabil., vol. 25, no. 3, pp. 669–685, Mar. 2016, doi: 10.1007/s11136-015-1112-6. Search in Google Scholar

[90] E. L. Bloom, H. Minami, R. A. Brown, D. R. Strong, D. Riebe, and A. M. Abrantes, “Quality of life after quitting smoking and initiating aerobic exercise,” Psychol. Health Med., vol. 22, no. 9, pp. 1127–1135, Oct. 2017, doi: 10.1080/13548506.2017.1282159. Search in Google Scholar

[91] M. C. Miguez et al., “Health-related quality of life among smoking relapsers,” Psicothema, vol. 30, no. 1, pp. 27–32, Feb. 2018, doi: 10.7334/psicothema2017.61. Search in Google Scholar

[92] G. Papadopoulos, C. I. Vardavas, M. Limperi, A. Linardis, G. Georgoudis, and P. Behrakis, “Smoking cessation can improve quality of life among COPD patients: validation of the clinical COPD questionnaire into Greek,” BMC Pulm. Med., vol. 11, p. 13, Feb. 2011, doi: 10.1186/1471-2466-11-13. Search in Google Scholar

[93] V. Fazekas-Pongor et al., “Health-related quality of life of COPD patients aged over 40 years,” Physiol. Int., Jun. 2021, doi: 10.1556/2060.2021.00017. Search in Google Scholar

[94] E. A. Flott, “Smoking Cessation Strategies for Patients with COPD,” Home Healthc. Now, vol. 33, no. 7, pp. 375–379, 2015, doi: 10.1097/NHH.0000000000000263. Search in Google Scholar